1. A classic case of amyloid cardiomyopathy. (9th October 2012) Authors: Jouni, Hayan; Morice, William G; Rajkumar, S Vincent; Herrmann, Joerg Journal: BMJ case reports Issue: Volume 2012 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An overview of the progress in the treatment of multiple myeloma. Issue 1 (February 2014) Authors: Kyle, Robert A; Rajkumar, S Vincent Journal: Expert review of hematology Issue: Volume 7:Issue 1(2014) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An overview of the progress in the treatment of multiple myeloma. Issue 1 (February 2014) Authors: Kyle, Robert A; Rajkumar, S Vincent Journal: Expert review of hematology Issue: Volume 7:Issue 1(2014) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial. Issue 10068 (4th February 2017) Authors: Durie, Brian G M; Hoering, Antje; Abidi, Muneer H; Rajkumar, S Vincent; Epstein, Joshua; Kahanic, Stephen P; Thakuri, Mohan; Reu, Frederic; Reynolds, Christopher M; Sexton, Rachael; Orlowski, Robert Z; Barlogie, Bart; Dispenzieri, Angela Journal: Lancet Issue: Volume 389:Issue 10068(2017) Page Start: 519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial. Issue 1 (January 2021) Authors: Usmani, Saad Z; Hoering, Antje; Ailawadhi, Sikander; Sexton, Rachael; Lipe, Brea; Hita, Sandi Fredette; Valent, Jason; Rosenzweig, Michael; Zonder, Jeffrey A; Dhodapkar, Madhav; Callander, Natalie; Zimmerman, Todd; Voorhees, Peter M; Durie, Brian; Rajkumar, S Vincent; Richardson, Paul G; Orlowski... Journal: Lancet Issue: Volume 8:Issue 1(2021) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 10 (October 2020) Authors: Kumar, Shaji K; Jacobus, Susanna J; Cohen, Adam D; Weiss, Matthias; Callander, Natalie; Singh, Avina K; Parker, Terri L; Menter, Alexander; Yang, Xuezhong; Parsons, Benjamin; Kumar, Pankaj; Kapoor, Prashant; Rosenberg, Aaron; Zonder, Jeffrey A; Faber, Edward; Lonial, Sagar; Anderson, Kenneth C; R... Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Issue 2 (February 2022) Authors: Raje, Noopur S; Anaissie, Elias; Kumar, Shaji K; Lonial, Sagar; Martin, Thomas; Gertz, Morie A; Krishnan, Amrita; Hari, Parameswaran; Ludwig, Heinz; O'Donnell, Elizabeth; Yee, Andrew; Kaufman, Jonathan L; Cohen, Adam D; Garderet, Laurent; Wechalekar, Ashutosh F; Terpos, Evangelos; Khatry, Navin; ... Journal: Lancet Issue: Volume 9:Issue 2(2022) Page Start: e143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Daratumumab in multiple myeloma. Issue 10027 (9th April 2016) Authors: Rajkumar, S Vincent Journal: Lancet Issue: Volume 387:Issue 10027(2016) Page Start: 1490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study. Issue 1 (January 2021) Authors: Laubach, Jacob P; Schjesvold, Fredrik; Mariz, Mário; Dimopoulos, Meletios A; Lech-Maranda, Ewa; Spicka, Ivan; Hungria, Vania T M; Shelekhova, Tatiana; Abdo, Andre; Jacobasch, Lutz; Polprasert, Chantana; Hájek, Roman; Illés, Árpád; Wróbel, Tomasz; Sureda, Anna; Beksac, Meral; Gonçalves, Iara Z; Bl... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival. (16th March 2017) Authors: Muchtar, Eli; Dispenzieri, Angela; Kumar, Shaji K.; Buadi, Francis K.; Lacy, Martha Q.; Zeldenrust, Steven; Hayman, Suzanne R.; Leung, Nelson; Kourelis, Taxiarchis V.; Gonsalves, Wilson; Chakraborty, Rajshekhar; Russell, Steven; Dingli, David; Lust, John A.; Lin, Yi; Kapoor, Prashant; Go, Ronald;... Journal: Amyloid Issue: Volume 24(2017)Supplement 1 Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗